PCOS患者におけるIVFのための卵巣刺激の最適化:新しい1日目のGNRH抗原プロトコル
Sudarsan Ghosh Dastidar1, Biswanath Ghosh Dastidar1,2, Ratna Chattopadhyay3
1GD Institute for Fertility Research, 36 A/1 S.P. Mukherjee Road, Kolkata 700025, West Bengal, India.
Journal of clinical medicine
|August 28, 2025
まとめ
卵巣刺激の1日目のGnRH抗体投与を開始した女性では,多囊性卵巣症候群 (PCOS) の女性で,体外受精 (IVF) を受けた女性では,卵巣の産量と胚の質が著しく改善され,結果が改善されたことが示唆されています.
科学分野:
- 生殖内分泌学
- 試管受精 で
- 卵巣刺激プロトコル
背景:
- ゴナドトロピン放出ホルモン (GnRH) 反抗剤のプロトコルは,その柔軟性,安全性および有効性のために,体外受精 (IVF) を受けている多囊性卵巣症候群 (PCOS) の女性に好ましい.
- GnRHアゴニストとアンタゴニストのプロトコルとの比較は存在するが,PCOS患者におけるGnRHアンタゴニスト投与の最適なタイミングに関する研究は限られている.
研究 の 目的:
- 多囊性卵巣症候群 (PCOS) の患者で,標準的な柔軟な5日/6日と早期の1日GnRH抗体投与プロトコルの間の実験室と臨床結果の比較.
主な方法:
- 回顧的なコホート研究設計
- 2つのGNRHアンタゴニスト投与プロトコルにおけるIVF結果の比較:標準的な柔軟性 (5/ 6日) と早期性 (1日)
- PCOS患者における検査結果と臨床妊娠率に焦点を当てた.
主要な成果:
- 1日目からGnRHアンタゴニストを投与された患者は,卵子細胞の生産量が著しく増加した.
- 1日抗体群では,高品質の胚の比率が高く見られた.
- 累積的な臨床妊娠率は,第1日の対抗薬群で改善傾向を示した.
結論:
- 卵巣刺激の1日目にGnRHアンタゴニスト投与を開始すると,IVFを受けているPCOS患者では生殖能力が向上する可能性があります.
- この患者集団におけるIVFの成功率を改善するための有望な戦略である.
関連する概念動画
Hormonal Control of the Ovarian Cycle
2.7K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
2.7K
Ovarian Cycle
1.8K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.8K
In Vitro Fertilization
385
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
385


